Segmenting and classifying tuberculosis, pneumonia and COVID-19 in chest X-rays
A deep learning pipeline that first isolates the lungs in a chest X-ray, then classifies the image as normal, tuberculosis, pneumonia or COVID-19.
AI for medical imaging and clinical risk, grounded in our published research.
Our MedTech work builds on peer-reviewed research in cardiovascular and stroke risk stratification, medical image segmentation and explainable AI. We design clinical AI to support clinicians with transparent reasoning, validated on the populations it will serve, and never to replace clinical judgement.
Where medtech makes the biggest difference for our clients.
A deep learning pipeline that first isolates the lungs in a chest X-ray, then classifies the image as normal, tuberculosis, pneumonia or COVID-19.
A review of transformer and attention-based deep learning architectures for outlining coronary artery walls in IVUS images, and where they outperform earlier networks.
A body of research on how AI can estimate cardiovascular and stroke risk in people with diabetes, Parkinson’s disease, rheumatoid arthritis, sleep apnoea and COVID-19.
A short workshop to understand the problem, the data and what success looks like.
A working proof of concept on a sample of your data, so you can judge results early.
The full solution, tested against your data and integrated with your systems.
Production deployment on your cloud, with monitoring and continuous improvement.
Clinical use depends on the specific product and regulatory pathway. We design studies and documentation to support approval, and say clearly when a tool is for research use only.
Yes. We work under data-sharing agreements, de-identify data and can train models inside your environment.
Start with a free discovery call. We will tell you honestly what is possible with your data.